Semen samples were obtained from 60 fertile (age 31.6 ± 3.3 years) and 60 subfertile (age 32.5 ± 3.23 years) men with asthenozoospermia between July 2011 to July 2012, from couples who had consulted the infertility clinic of Babil Hospital of Maternity (Hilla city/ IRAQ). The subfertile group was treated with zinc sulfate, with every participant taking two capsules of zinc sulfate per day for three months (each one 220mg). Semen samples were obtained (before and after zinc sulfate supplementation). After liquefaction, seminal fluid at room temperature, routine semen analyses were performed.
Introduction
Male factor infertility is the exclusive reason for infertility in about 20% of infertile couples, and in 30% to 40% of couples, both male and female factors are involved. Thus, half of all infertility can be recognized in part or absolutely to be caused by a male factor (Patel and Niederberger, 2011) . There are several causes of male infertility, including oxidative stress, and nutritional deficiency of trace elements like selenium and zinc (Wong et al., 2000; Olayemi, 2010) . The Zn is second only to iron as the most abundant trace element in the body. Although Zinc is found in red meat, white meat, fish, and milk, the World Health Organization (WHO) estimates that one-third of the world's population is deficient in Zn (Khan et al., 2011) . Zinc serves as a cofactor for more than 80 metalloenzymes involved in DNA transcription and protein synthesis. These two pathways are major components of germ cell maturity; for this reason, zinc is believed to be important for reproduction. Zinc is essential for testicular development and differentiation, formation and maturation of spermatozoa, synthesis and secretion of luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone and 5α-dihydrotestosterone, acrosin activity, the acrosome reaction and therefore fertilization. Moreover, zinc-binding proteins are implicated in the genetic expression of steroid hormone receptors (Favier, 1992; Freedman, 1992) and zinc also has anti-apoptotic (Chimienti et al., 2003) and antioxidant properties (Zago and Oteiza, 2001 ).
There are multiples pieces of evidence that injury caused to spermatozoa by reactive oxygen species (ROS) plays a key role in the etiology of male infertility (Iwasaki and Gagnon, 1992; Aitken and Sawyer, 2003) . Spermatozoa have large quantities of polyunsaturated fatty acids in their plasma membrane and low levels of scavenging enzymes in their cytoplasm. Therefore, it is subject to peroxidation from elevated seminal reactive oxygen species levels (Sharma and Agarwal, 1996) . Oxidative stress has been identified as an imbalance between the production of reactive oxygen species (ROS) and antioxidant-scavenging activities, in which the generation of ROS overcomes (Sikka, 2001) . Human spermatozoa generate reactive oxygen species (ROS) in physiologic amounts from activities such as capacitation, the acrosome reaction, and oocyte fusion (de Lamirande and Gagnon, 1993; Saleh and Agarwal, 2002) . However, too much ROS production, when it exceeds the limited antioxidant defenses in semen, results in spermatozoa dysfunction (Agarwal et al., 2003) . 25-88% of nonselected subfertile patients have high levels of seminal ROS (Lewis et al., 1995) . Also, subfertile males with high levels of ROS have 1/7 the likelihood of initiating a pregnancy compared with those with low ROS levels (Sharma el al., 1999) . Seminal oxidative stress results in decreased semen quality by several mechanisms, including injury of the sperm membrane and/or DNA (Lewis et al., 1995) .
Given the complexity of reaching a precise identification and the hope of improving semen quality, many antioxidant therapies have been used to treat infertility. Treatments have varied over the years and have involved the use of many different compounds including carnitines, phosphatidylcholine, kallikrein, pentoxifylline and vitamins A, E and C, without particular attention to counteracting the lipoperoxidative damage (Lanzafame, 2009) . The objective of this study was to evaluate seminal plasma total antioxidant capacity (TAC) in infertile patients (before and after treatment with zinc sulfate) with asthenozoospermia in relationship to their seminal parameters.
Materials and Methods

Patients
This study includes 60 subfertile male partners between July 2011 to July 2012, from couples who had consulted the infertility clinic of Babil Hospital of Maternity (Hilla city/ IRAQ). The approval of the Institutional Research Ethics Committee and consent of every patients included in the study were obtained. A detailed medical history was taken and physical examination was performed. The inclusion criteria were the presence of asthenozoospermia in the semen sample and absence of endocrinopathy, varicocele, and female factor infertility.
Semen analyses
Semen samples were obtained from 60 fertile (age 31.6 ± 3.3 years) and 60 subfertile (age 32.5 ± 3.23 years) men with asthenozoospermia by masturbation after three days of sexual abstinence. The subfertile group was treated with zinc sulfate, with every participant taking two capsules of zinc sulfate per day for three months (each one 220 mg). Semen samples were obtained (before and after zinc sulfate supplementation). After liquefaction of seminal fluid at room temperature, routine semen analyses including volume, pH, concentration, sperm motility, normal sperm morphology and round cells were performed according to 2010 WHO recommendations.
Preparation of seminal plasma and spermatozoa for biochemical analysis
For each sample, seminal plasma was separated from the spermatozoa 1 h after semen collection by centrifugation of 2 ml of seminal fluid at 1500 g for 10 min at 4°C and maintained at -30°C until analysis. the pellet was resuspended in 10 volumes of medium NTPC (NaCl 113 mM (0.66 g/100 ml), NaH2PO4 2.5 mM (0.3 g/100 ml), Na2HPO4 2.5 mM (0.0355 g/100 ml), CaCl2 1.7 mM (0.0188 g/100 ml), D-glucose 1.5 mM (0.0027 g/100 ml), Tris 20 mM(0.242 g/100 ml), EDTA 0.4 mM (0.0148 g/100 ml) adjusted to pH 7.4 with HCl) and centrifuged at 1500 g for 10 min at 4°C. This washing procedure was repeated three times. Triton X-100 (0.1%) was added to the pellets obtained and the samples centrifuged again at 8000 rpm for half an hour in a refrigerated centrifuge. This concentration of Triton X-100 does not affect enzyme levels. The supernatant was used for measurements in spermatozoa. (Apak et al., 2005; Apak et al., 2007; Özyürek et al., 2008; The reduction potential of the sample or standard effectively converts Cu +2 to Cu +1 , thus changing the ion's absorption characteristics. This reduced form of copper will selectively form a stable 2:1 complex with the chromogenic reagent (Neocuproine (Nc){2,9-dimethyl-1,10-phenanthroline}) with an absorption maximum at 450 nm. A known concentration of standard (Working standard solution: composed from three equal volumes of 1.0 * 10 -3 M of α-Tocopherol (0.0402 g/100 ml dichloromethane), ascorbic acid (0.1761 g/100 ml DW) and glutathione (GSH) (0.0307 g/100 ml DW)) is used to create a calibration curve, with the data expressed as mM standard equivalents.
Total antioxidant capacity:
Statistical analysis
Student t-tests were used for statistical analyses.
Results
In Table 1 , the baseline characteristics of semen parameters are depicted in the fertile and subfertile (before and after treatment with zinc sulfate) groups. The semen parameters were significantly different between the groups. Patients before treatment 1.83 ± 0.66 * 67 ± 11 * 21 ± 9 * 67 ± 11
Patients after treatment 2.39 ± 0.9 ** 70 ± 15 39 ± 14 ** 73 ± 7 ** Sn1 *: significance versus group I (Healthy donors). Sn2 **: significance versus group II (Patients before treatment). Table ( 2 and 3) show the total antioxidant levels in the fertile and subfertile (before and after treatment with zinc sulfate) groups. This parameter was significantly (p<0.05) decreased in infertile group when compared with healthy donor group. However, the level of total antioxidants was significantly (p<0.05) increased (return to normal value) after zinc sulfate supplementation. Seminal analysis and total antioxidant levels were measured for a group of subfertile patients without any treatment before and after the experiment. No significant change was found between measurements before and after the experiment (for subfertile patients without any treatment), based on statistical analysis (student t-test). The comparison of the results obtained before and after the experiment were the same (data not shown).
Discussion
In this study, the effect of zinc supplementation on semen quantitative and qualitative characteristics of infertile men with asthenozoospermia was studied. The results revealed that supplementation of Zn in form (zinc sulfate) improved the semen quality of infertile men as compared to the same group before supplementation of Zn sulfate. This study confirms many previous studies (Stankovic and Mikac-Devic, 1976; Hartoma et al., 1977; Kynaston, et al., 1988; Ebisch et al., 2006; Wong et al.,2002; ) . Some of the results of this study, such as the sperm count and motility, are consistent with earlier studies and differ in other, such as sperm morphology.
The results showed significantly (P< 0.05) higher values of ejaculate volume in-the group supplemented with Zn sulfate as compared to the same group before supplementation of Zn sulfate. Semen volume mainly represents secretion of the testes, epididymis and accessory sex glands, principally the prostate gland (Elzanaty et al., 2004) . Zn has been established to stimulate the growth and development of sex organs as evidenced by the link between Zn deficiency and hypogonadism and insufficient development of sex characteristics (testes, epididymis and accessory sex glands, especially prostate gland) in humans (Sandstorm and Sandberg, 1992; Endre et al., 1990 ).
In the present study, we recorded a significant (P<0.05) increase in the sperm count of group supplemented with Zn sulfate compared to the same group before supplementation of Zn. This effect may be due to a key role of Zn in spermatogenesis (Madding et al., 1986) . Zinc induces spermatogenesis via several mechanisms; the first includes influencing mitotic and meiotic cell divisions, along with synthesis of DNA and RNA by increasing the activity of DNA polymerase and RNA polymerase, the two zinc-containing enzymes (Bedwal and Bahuguna, 1994) . The second involves the participation of zinc in the activation and protection of the germinal epithelium of seminiferous tubules and also the stimulation of production and secretion of testosterone, which influences spermatogenesis (Wong et al., 2002) . The third mechanism involves the attachment of zinc to the most important enzymes involved in the process of spermatogenesis such as sorbitol dehydrogenase and lactate dehydrogenase (Eggert et al., 2002) . The last mechanism involves the participation of zinc in the synthesis and activation of testosterone. Scientific studies with adult males experimentally deprived of dietary zinc have shown that Leydig cell production of testosterone is subject to sufficient dietary zinc (Hunt et al., 1992) . Moreover, zinc plays a fundamental role in the 5α-reductase enzyme that is essential for the conversion of testosterone into the biologically active form, 5 α-dihydrotestosterone (DHT). Netter et al., (1981) found a significant increase in testosterone, DHT, and zinc plasma levels after 40-50 days of zinc supplementation in patients with idiopathic male factor subfertility.
The results demonstrate significantly (P< 0.05) higher values of normal morphology in the group supplemented with Zn sulfate as compared to the same group before supplementation of Zn. The results of this study are not compatible with the results of other studies conducted on humans (Wong et al., 2002) or animal models (Kumar et al., 2006) . Kumar et al., (2006) attributed the cause of the lack of improvement in the normal morphology to the absence of the effect of zinc on Sertoli cells. These cells are responsible for the spermiogenesis phase of spermatogenesis, and thus regulate normal and abnormal morphology of sperm. We believe that this view is inaccurate because zinc has an essential role in the synthesis and secretion of follicle-stimulating hormone (FSH) (Om and Chung, 1996; Bedwal and Bahuguna, 1994) , where FSH induces Sertoli cells of the testes to support the germ cells in undergoing spermiogenesis (Wistuba et al., 2007 ).
The results demonstrate significantly (P< 0.05) higher values of motility in the group supplemented with Zn sulfate as compared to the same group before supplementation of Zn. The antioxidant action of Zn may be responsible for improved motility of sperm in Zn-supplemented groups via enhancement of Creatine Kinase activity. It's a key enzyme of cellular energy metabolism, which catalyses the reversible transfer of the high energy N-phospho-group from phosphocreatine to ADP (Forstener et al., 1998) , thus, stabilizing ATP levels. ATP is the primary donor of energy needed by the sperm flagella for movement (El-Masry et al., 1994) . The active sites of CK contain cysteine residues that are essential for enzyme activity and substrate binding (Liu and Zhou, 1995) . Cysteines are also the target of oxygen free radicals, which modify and inactivate the enzyme. The inactivation effects of superoxide radical and hydroxyl radical are reversible as opposed to peroxinitrite, which was reported to be irreversible (Konorev and Kalyanarman, 1998) . This is another reason for the enhancement of sperm motility in Zn-supplemented groups beyond increasing the activity of Zn-containing enzymes such as sorbitol dehydrogenase and lactate dehydrogenase which play significant roles in sperm motility (Wong et al.,2002) .
We believe that the antioxidant property of zinc is the essential reason for the enhancement of semen quantitative and qualitative characteristics (count, motility, morphology) of infertile men with asthenozoospermia after supplementation. To clarify this role, TAC was measured using the CUPRAC method. The total antioxidative capacity is not a simple summation of the activities of the different antioxidative substances. It is a dynamic equilibrium influenced by the communication between each antioxidative constituent. It is thought that the cooperation of antioxidants in human semen provides greater defense against attacks by free radicals than any antioxidant alone (Wayner et al., 1987) . Our study is perhaps the first study to correlate semen quality with TAC (CUPRAC) of infertile men with asthenozoospermia. The advantages of the CUPRAC method over other similar assays include the ability to measure glutathione . The CUPRAC reagent is fast enough to oxidize thiol-type antioxidants, whereas according to the protocol described by Benzie and Strain (1996) , the FRAP method does not measure certain thiol-type antioxidants like glutathione or ergothionine. The CUPRAC reagent is selective, because it has a lower redox potential than the ferric-ferrous couple in the presence of specific ligands like phenanthroline. The standard potential of the Cu(II,I)-Neocuproine redox couple is about 0.6 V, near to that of ABTS + /ABTS= 0.68 V, i.e., simple sugars and citric acid, which are not true antioxidants, are not oxidized with the CUPRAC reagent. There have been several studies investigating TAC that have used methods other than CUPRAC (Giulini, 2009; Smith et al., 1996; Koca et al., 2003; Meucci et al., 2003; Mahfouz et al., 2009 ). This study found a significant decrease in total antioxidant level of asthenozoospermic group when compared to fertile controls. Similarly, Agarwal and coworker (1994) reported that ROS levels in subfertile men were considerably higher than in normal men, believed to be the result of lower antioxidant capacity. The production of excess ROS in semen is positively linked with low sperm concentration, poor motility, and poor morphology. As a result, previous studies concluded that the evaluation of ROS levels in cases of idiopathic male infertility could provide an important indicator of sperm dysfunction.
In the present study, we recorded a significant (P<0.05) increase in total antioxidant capacity of the group supplemented with Zn sulfate as compared to the same group before supplementation of Zn. This increment could be related to the antioxidant property of zinc and consequently the enhancement of semen quantitative and qualitative characteristics (count, motility, morphology) of infertile men with asthenozoospermia after supplementation. Total seminal plasma antioxidants are the most defensive mechanism obtainable to spermatozoa against ROS, which may be influenced by a number of factors such as nutrition, vitamin supply, age and infection (Miller et al., 1997) . Seminal TAC has been shown to be related to male infertility (Agarwal et al., 2006) , therefore, it is important to precisely estimate the total antioxidant amount of the seminal plasma.
In conclusion, based upon our data, we propose that decreased TAC is correlated with impaired sperm parameters, which can lead to infertility. The possible causes for decreased antioxidant activity may be either increased ROS production or insufficient antioxidant activity. Zinc supplementation restores TAC to a normal range and enhances semen quantitative and qualitative properties.
